Fundraising Fox

SciFounders β€” Full Portfolio

21 tracked investments Β· listed companies and verified rows first

Luminateluminatemed.comin𝕏Jan 2026 Β· $21Mβœ“ verified

Luminate develops medical device technology to address chemotherapy side effects, particularly hair loss and peripheral neuropathy, for oncology patients and healthcare providers.

BiotechDigital HealthHealthtechMedical DevicesGalway, US

Aaron Hannon(Founder)inBarbara Oliveira(Founder)inProf. Martin O'Halloran(Co-founder)inJAMES EVERINGHAM(Executive Officer, Director)

BoardTOD FRANCIS(Director)ROBERT LISBONNE(Executive Officer, Director)

Co-investorsY Combinator8VCArtis VenturesFaberMetaplanetLachy Groom

Xternaxterna.bioinβœ“ verified

Xterna develops xeno nucleic acid (XNA) technology to engineer cell-specific binders aimed at treating diseases currently considered untreatable.

BiotechDeep TechHealthtech

Co-investorsReinforced VenturesBoxOne Ventures

Conceptionconception.bioin

Conception develops stem cell technology to create functional reproductive cells in the laboratory, enabling in-vitro gametogenesis as a solution for individuals facing biological and medical fertility barriers.

BiotechDeep TechHealthtech

Matt Krisiloff(CEO)inBianka Seres(President)

Co-investorsage1CompoundHOF CapitalMetaplanetVU Venture Partners

Current Surgicalcurrentsurgical.comin𝕏

Current Surgical develops a smart needle technology platform for surgical treatment of cancerous tumors.

Deep TechHealthtechMedical DevicesWashington, US

Co-investorsTrue VenturesCarbon SiliconDraper Associates

Deliverbiodeliverbio.comin𝕏

Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells inside patients (in vivo) for cell and gene therapies, using programmable targeting to transport payloads such as DNA and mRNA to specific cell types.

BiotechDeep TechHealthtech

EARTH AIearth-ai.comin𝕏

Earth AI uses AI to locate critical mineral deposits by analyzing geological data, supporting the supply chain for hardware and emerging technologies.

Advanced ManufacturingAI & Machine LearningClimate TechDeep TechNew MaterialsSan Francisco, US

Roman Teslyuk(Founder)in

BoardIan Rountree(Director)inMikhail Taver(Director)Jamie Lee(Director)inIsabella Sykes(Director)Arnoud Balhuizen(Director)

Co-investorsAirTree VenturesAlpaca VCBlackbird VenturesCantos VenturesCorigin VenturesDCVC (Data Collective)+12 more

Enduraenduratx.comin

EnduraTx develops small-molecule medicines that form permanent covalent bonds with disease-causing RNA to block production of proteins that cannot be drugged at the protein level, targeting conditions such as certain cancers and neurodegenerative diseases.

AI & Machine LearningBiotechDeep Tech

Co-investorsMoxxie VenturesScribble Ventures

Engage Bioengagebio.cominAcquired

EngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.

BiotechDigital HealthHealthtechSan Francisco, US

Will Olsen(Founder)in

Co-investorsMetaplanetWorldQuant VenturesY Combinator

Fletcherbiofletcherbio.comin

Fletcher Bio engineers natural immune proteins using protein design to create precision immunotherapies that target and eliminate autoreactive T cells.

AI & Machine LearningBiotechDeep Tech

Fluorescent-guided surgery
Harborsiteharborsite.comin𝕏

HarborSite develops a targeted gene insertion platform that engineers site-specific recombinase enzymes to integrate therapeutic genes into safe genomic sites.

BiotechDeep TechLongevity

Erik Aznauryan, PhD(Founder)in

Co-investorsFifty YearsSmartGateVC

In vivo cell editing
Mammoth Bio

Company started by the SciFounders team developing impactful technologies; has raised roughly $450M.

Moabtxmoabtx.bioin

MOAB develops minibinders β€” small, stable, modular protein binders based on natural scaffolds β€” for use as new therapeutics.

AI & Machine LearningBiotechDeep Tech

NewLimitnewlimit.com𝕏May 2025

NewLimit develops epigenetic reprogramming medicines to extend healthspan and treat age-related diseases at the intersection of computer science and biotechnology.

AI & Machine LearningBiotechLongevitySouth San Francisco, US

Brian Armstrong(Co-founder, Board of Directors)inBlake Byers(Director)inJacob Kimmel(Director)inMichael Polansky(Executive Officer)

BoardZavain Dar(Director)in

Co-investorsS32Valor Equity Partners8VCAbstract Venturesage1Beyond Capital+6 more

Olio Labsoliolabs.coin

Olio Labs develops drug combination therapies using machine learning to identify treatments that target multiple interacting proteins simultaneously, with initial candidates focused on obesity treatment.

BiotechHealthtech

David Tingley(Founder)inTom Roseberry(Founder)in

Co-investorsOverwater Ventures LlcScrum VenturesY CombinatorZAKA VC

Preventivepreventive.bioin𝕏

Preventive.bio focuses on preventing disease before birth.

BiotechFemTechHealthtech

Co-investorsHOF Capital

Sculptasculpta.bio

Co-investorsFifty Years

The future of cancer care
Trace Biotrace-bio.comin

Trace Biosciences develops targeted fluorescent imaging agents, called Nerve Trace, that highlight nerves in real time during surgery so surgeons and surgical robots can avoid nerve damage.

BiotechHealthtechMedical DevicesBeaverton, US

Connor Barth(Executive Officer, Director)Summer Gibbs(Executive Officer, Director)Lei Wang(Executive Officer, Director)Jonathan Sorger(Director)

Co-investorsElevate Capital

Velorum Therapeuticsvelorumtx.comin𝕏

Velorium develops transformational medicines by combining scientific research with patient-focused collaboration.

BiotechHealthtechMedical DevicesSan Francisco, US

Pouya Modareszadeh(Founder)inParsa Modareszadeh(Founder)in

Co-investorsMetaplanetMyAsiaVCY Combinator468 CapitalRitual Capital

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.